| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 440,2 k € | +15.2% | 382,0 k € | +5.5% | 362,2 k € | +11.1% | 326,1 k € | +25.1% | 260,5 k € | +7.7% | 241,9 k € | +23.5% | 196,0 k € | -27.7% | 271,0 k € | +33.7% | 202,7 k € | +35.9% | 149,1 k € | -24.2% | 196,7 k € | +50.1% | 131,1 k € | -18.8% | 161,4 k € | +23.0% | 131,2 k € | -28.5% | 183,4 k € | +212.1% | 58,8 k € | |
| EBITDA | 438,5 k € | +117.5% | 201,7 k € | -43.8% | 358,9 k € | +11.1% | 322,9 k € | +25.5% | 257,4 k € | +8.0% | 238,3 k € | +22.9% | 193,8 k € | -28.1% | 269,5 k € | +33.9% | 201,2 k € | +36.3% | 147,7 k € | -24.6% | 195,8 k € | +50.4% | 130,1 k € | -18.9% | 160,5 k € | +23.4% | 130,1 k € | -28.8% | 182,6 k € | +213.1% | 58,3 k € | |
| Operating profit | 437,2 k € | +117.3% | 201,2 k € | -41.7% | 345,1 k € | +13.1% | 305,2 k € | +30.8% | 233,2 k € | +9.5% | 213,1 k € | +42.5% | 149,5 k € | -36.8% | 236,5 k € | +38.9% | 170,2 k € | +44.5% | 117,8 k € | -26.4% | 160,1 k € | +49.8% | 106,9 k € | -22.1% | 137,2 k € | +28.5% | 106,8 k € | -34.1% | 162,1 k € | +264.0% | 44,5 k € | |
| Profit/loss | 301,6 k € | +122.7% | 135,4 k € | -40.7% | 228,6 k € | +8.8% | 210,1 k € | +18.0% | 178,1 k € | +21.2% | 147,0 k € | +21.4% | 121,1 k € | -33.1% | 181,1 k € | +58.8% | 114,0 k € | +44.5% | 78,9 k € | -26.8% | 107,8 k € | +49.5% | 72,1 k € | -24.2% | 95,1 k € | +18.6% | 80,2 k € | -26.3% | 108,9 k € | +305.4% | 26,9 k € | |
| Equity | 2,3 M € | +15.1% | 2,0 M € | +2.3% | 1,9 M € | +13.3% | 1,7 M € | +41.8% | 1,2 M € | +14.0% | 1,1 M € | +10.1% | 961,2 k € | +8.0% | 890,1 k € | +17.3% | 759,0 k € | +17.7% | 645,0 k € | +13.9% | 566,1 k € | +23.5% | 458,3 k € | +18.7% | 386,2 k € | +32.7% | 291,0 k € | +38.1% | 210,8 k € | +106.9% | 101,9 k € | |
| Total assets | 2,4 M € | +16.1% | 2,1 M € | +1.4% | 2,1 M € | +11.5% | 1,9 M € | +31.7% | 1,4 M € | +8.8% | 1,3 M € | +5.9% | 1,2 M € | +5.8% | 1,2 M € | +6.8% | 1,1 M € | -1.5% | 1,1 M € | +4.3% | 1,1 M € | +12.1% | 942,2 k € | +121.5% | 425,3 k € | +29.9% | 327,4 k € | +5.6% | 310,1 k € | +64.7% | 188,2 k € | |
| Cash | 574,0 k € | -16.1% | 684,4 k € | +10.5% | 619,1 k € | +27.7% | 484,9 k € | +77.1% | 273,8 k € | +103.2% | 134,8 k € | -78.6% | 630,8 k € | +11.7% | 564,9 k € | +394.3% | 114,3 k € | +1615.0% | 6,7 k € | -85.5% | 45,9 k € | -13.5% | 53,0 k € | -15.0% | 62,4 k € | +107.9% | 30,0 k € | -39.2% | 49,3 k € | +447.5% | 9,0 k € | |
| Debts | 150,7 k € | +32.2% | 114,0 k € | -11.8% | 129,2 k € | -10.5% | 144,3 k € | -29.6% | 204,9 k € | -14.0% | 238,3 k € | -9.6% | 263,6 k € | -1.6% | 267,9 k € | -17.7% | 325,4 k € | -28.7% | 456,5 k € | -6.9% | 490,0 k € | +1.3% | 483,9 k € | +1136.8% | 39,1 k € | +7.7% | 36,3 k € | -63.4% | 99,3 k € | +21.9% | 81,4 k € | |
Private limited company · Izegem · incorporated on 09/01/2007
Private limited company profitable and well capitalised. Cash position declining (-16.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. K. BOEL is a Private limited company incorporated in 2007. Its main activity is: Specialist medical practice activities. Its registered office is in Izegem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette